TreeWAS
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs3914502
log Bayes Factor = <0.0001
Chromosome 3   position 174,564,602  (GRCh37) Explore rs3914502 on Ensembl!
Variant rs3914502 is listed in the   GWAS Catalog  

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
No effect
posterior probability
Protective
posterior probability
 
I42.9 Cardiomyopathy, unspecified
0.000 0.960 0.040
I42 Cardiomyopathy
0.000 0.968 0.032
I42.1 Obstructive hypertrophic cardiomyopathy
0.000 0.969 0.031
I42.2 Other hypertrophic cardiomyopathy
0.000 0.975 0.025
I42.7 Cardiomyopathy due to drugs and other external agents
0.000 0.975 0.025
I42.5 Other restrictive cardiomyopathy
0.000 0.976 0.024
I42.3 Endomyocardial (eosinophilic) disease
0.000 0.977 0.023
I42.8 Other cardiomyopathies
0.000 0.977 0.023
I42.0 Dilated cardiomyopathy
0.000 0.978 0.022
I42.6 Alcoholic cardiomyopathy
0.000 0.980 0.020
I42.4 Endocardial fibroelastosis
0.000 0.981 0.019
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.987 0.013
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.987 0.013
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.987 0.013
Y83.3 Surgical operation with formation of external stoma
0.000 0.988 0.012
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.988 0.012
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.989 0.011
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.990 0.009
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.990 0.009
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.990 0.009
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.990 0.009
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.990 0.009
T44.0 Anticholinesterase agents
0.000 0.990 0.009
G50.0 Trigeminal neuralgia
0.000 0.991 0.009
Z90.3 Acquired absence of part of stomach
0.000 0.993 0.007
H54.4 Blindness, one eye
0.000 0.993 0.007
S72.20 Subtrochanteric fracture (closed)
0.000 0.993 0.007
L98.0 Pyogenic granuloma
0.000 0.994 0.006
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.006 0.994 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.994 0.006
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.994 0.006
N94.6 Dysmenorrhoea, unspecified
0.006 0.994 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.994 0.006
H54.7 Unspecified visual loss
0.000 0.994 0.006
L90.5 Scar conditions and fibrosis of skin
0.006 0.994 0.000
I44.0 Atrioventricular block, first degree
0.005 0.995 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.995 0.005
H54 Blindness and low vision
0.000 0.995 0.005
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.995 0.005
T46.1 Calcium-channel blockers
0.000 0.995 0.005
T40.6 Other and unspecified narcotics
0.000 0.995 0.005
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.995 0.005
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.995 0.005
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.995 0.005
M79.63 Pain in limb (Forearm)
0.000 0.995 0.005
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.995 0.004
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.995 0.004
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.996 0.004
Z63.0 Problems in relationship with spouse or partner
0.000 0.996 0.004
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.996 0.004
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.996 0.004
H54.9 Unspecified visual impairment (binocular)
0.000 0.996 0.004
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.996 0.004
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.996 0.004
T46.7 Peripheral vasodilators
0.000 0.996 0.004
G95.2 Cord compression, unspecified
0.004 0.996 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.996 0.004
T43.6 Psychostimulants with abuse potential
0.000 0.996 0.004
H54.1 Blindness, one eye, low vision, other eye
0.000 0.996 0.004
K59.8 Other specified functional intestinal disorders
0.000 0.996 0.004
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.996 0.004
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.996 0.004
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.996 0.004
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.996 0.004
W18.5 Trade and service area
0.004 0.996 0.000
G95.0 Syringomyelia and syringobulbia
0.004 0.996 0.000
H54.6 Unqualified visual loss, one eye
0.000 0.996 0.004
T42.0 Hydantoin derivatives
0.000 0.996 0.004
G95.1 Vascular myelopathies
0.004 0.996 0.000
H54.3 Unqualified visual loss, both eyes
0.000 0.996 0.004
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.996 0.004
J37.0 Chronic laryngitis
0.004 0.996 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.996 0.004
G95 Other diseases of spinal cord
0.004 0.996 0.000
T40.4 Other synthetic narcotics
0.000 0.996 0.004
T45.2 Vitamins, not elsewhere classified
0.000 0.996 0.004
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.996 0.004
T36 Poisoning by systemic antibiotics
0.000 0.996 0.004
T45.0 Antiallergic and antiemetic drugs
0.000 0.996 0.004
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.996 0.004
N93.8 Other specified abnormal uterine and vaginal bleeding
0.004 0.996 0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.996 0.004
T40.8 Lysergide [LSD]
0.000 0.996 0.004
T40.7 Cannabis (derivatives)
0.000 0.996 0.004
T40.3 Methadone
0.000 0.996 0.004
T40.0 Opium
0.000 0.996 0.004
T47.2 Stimulant laxatives
0.000 0.996 0.004
T45.1 Antineoplastic and immunosuppressive drugs
0.000 0.996 0.004
W18.3 Sports and athletics area
0.004 0.996 0.000
T43.9 Psychotropic drug, unspecified
0.000 0.996 0.003
I98.2 Oesophageal varices in diseases classified elsewhere
0.000 0.996 0.004
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.996 0.003
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.996 0.003
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.996 0.003
T45.8 Other primarily systemic and haematological agents
0.000 0.996 0.003
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.996 0.003
T45.6 Fibrinolysis-affecting drugs
0.000 0.996 0.003
T45.4 Iron and its compounds
0.000 0.996 0.003
T45.3 Enzymes, not elsewhere classified
0.000 0.996 0.003
T48.5 Anti-common-cold drugs
0.000 0.996 0.003
H54.5 Low vision, one eye
0.000 0.997 0.003
H54.2 Low vision, both eyes
0.000 0.997 0.003
S72.2 Subtrochanteric fracture
0.000 0.997 0.003
T49.9 Topical agent, unspecified
0.000 0.997 0.003
T49.8 Other topical agents
0.000 0.997 0.003
T49.7 Dental drugs, topically applied
0.000 0.997 0.003
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.997 0.003
T49.5 Ophthalmological drugs and preparations
0.000 0.997 0.003
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.997 0.003
T49.3 Emollients, demulcents and protectants
0.000 0.997 0.003
T49.2 Local astringents and local detergents
0.000 0.997 0.003
T49.1 Antipruritics
0.000 0.997 0.003
T47.0 Histamine H(2)-receptor antagonists
0.000 0.997 0.003
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.997 0.003
T41.5 Therapeutic gases
0.000 0.997 0.003
T41.4 Anaesthetic, unspecified
0.000 0.997 0.003
T41.3 Local anaesthetics
0.000 0.997 0.003
T41.2 Other and unspecified general anaesthetics
0.000 0.997 0.003
T41.1 Intravenous anaesthetics
0.000 0.997 0.003
T41.0 Inhaled anaesthetics
0.000 0.997 0.003
G95.9 Disease of spinal cord, unspecified
0.003 0.997 0.000
H18.5 Hereditary corneal dystrophies
0.003 0.997 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.997 0.003
I87.2 Venous insufficiency (chronic) (peripheral)
0.000 0.997 0.003
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.997 0.003
T37.5 Antiviral drugs
0.000 0.997 0.003
T37.4 Anthelminthics
0.000 0.997 0.003
T37.3 Other antiprotozoal drugs
0.000 0.997 0.003
T37.1 Antimycobacterial drugs
0.000 0.997 0.003
T37.0 Sulphonamides
0.000 0.997 0.003
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.997 0.003
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.997 0.003
T47.7 Emetics
0.000 0.997 0.003
T47.5 Digestants
0.000 0.997 0.003
T47.3 Saline and osmotic laxatives
0.000 0.997 0.003
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.997 0.003
T48.4 Expectorants
0.000 0.997 0.003
T48.3 Antitussives
0.000 0.997 0.003
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.997 0.003
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.997 0.003
T48.0 Oxytocic drugs
0.000 0.997 0.003
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.997 0.003
O16 Unspecified maternal hypertension
0.003 0.997 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.997 0.003
T40.1 Heroin
0.000 0.997 0.003
T47.6 Antidiarrhoeal drugs
0.000 0.997 0.003
O14.9 Preeclampsia, unspecified
0.003 0.997 0.000
T40.5 Cocaine
0.000 0.997 0.003
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.997 0.003
T42.2 Succinimides and oxazolidinediones
0.000 0.997 0.003
T47.4 Other laxatives
0.000 0.997 0.003
I98.3 Oesophageal varices with bleeding in diseases classified elsewhere
0.000 0.997 0.003
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.997 0.003
W18 Other fall on same level
0.003 0.997 0.000
T36.9 Systemic antibiotic, unspecified
0.000 0.997 0.003
T36.7 Antifungal antibiotics, systemically used
0.000 0.997 0.003
T36.6 Rifamycins
0.000 0.997 0.003
T36.5 Aminoglycosides
0.000 0.997 0.003
T36.2 Chloramphenicol group
0.000 0.997 0.003
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.997 0.003
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.997 0.003
T40.2 Other opioids
0.000 0.997 0.003
H54.0 Blindness, both eyes
0.000 0.997 0.003
T36.0 Penicillins
0.000 0.997 0.003
H18 Other disorders of cornea
0.003 0.997 0.000
T42.3 Barbiturates
0.000 0.997 0.003
T36.3 Macrolides
0.000 0.997 0.003
T36.4 Tetracyclines
0.000 0.997 0.003
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.997 0.003
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.997 0.003
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.997 0.003
H18.9 Disorder of cornea, unspecified
0.003 0.997 0.000
M82.11 Osteoporosis in endocrine disorders (Shoulder region)
0.003 0.997 0.000
T36.8 Other systemic antibiotics
0.000 0.997 0.003
M43.17 Spondylolisthesis (Lumbosacral region)
0.000 0.997 0.003
T50.7 Analeptics and opioid receptor antagonists
0.000 0.997 0.003
T50.5 Appetite depressants
0.000 0.997 0.003
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.997 0.003
T50.0 Mineralocorticoids and their antagonists
0.000 0.997 0.003
I98 Other disorders of circulatory system in diseases classified elsewhere
0.000 0.997 0.003
T45.5 Anticoagulants
0.000 0.997 0.003
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.997 0.003
N83.1 Corpus luteum cyst
0.003 0.997 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.997 0.003
S72.21 Subtrochanteric fracture (open)
0.000 0.997 0.003
H18.6 Keratoconus
0.003 0.997 0.000
D89.2 Hypergammaglobulinaemia, unspecified
0.003 0.997 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.997 0.003
T50.4 Drugs affecting uric acid metabolism
0.000 0.997 0.003
Z03.9 Observation for suspected disease or condition, unspecified
0.003 0.997 0.000
N80.8 Other endometriosis
0.000 0.997 0.003
T38.9 Other and unspecified hormone antagonists
0.000 0.997 0.002
T38.7 Androgens and anabolic congeners
0.000 0.997 0.002
T38.5 Other oestrogens and progestogens
0.000 0.997 0.002
T38.4 Oral contraceptives
0.000 0.997 0.002
T38.2 Antithyroid drugs
0.000 0.997 0.002
Y45.2 Propionic acid derivatives
0.003 0.997 0.000
H18.8 Other specified disorders of cornea
0.003 0.997 0.000
T38.0 Glucocorticoids and synthetic analogues
0.000 0.997 0.002
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.997 0.002
G97.8 Other postprocedural disorders of nervous system
0.003 0.997 0.000
O14 Gestational [pregnancy-induced] hypertension with significant proteinuria
0.003 0.997 0.000
H18.3 Changes in corneal membranes
0.002 0.997 0.000
H18.0 Corneal pigmentations and deposits
0.002 0.997 0.000
T50.1 Loop [high-ceiling] diuretics
0.000 0.997 0.002
L43.9 Lichen planus, unspecified
0.003 0.997 0.000
T42.1 Iminostilbenes
0.000 0.997 0.002
L90 Atrophic disorders of skin
0.003 0.997 0.000
O10-O16 Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium
0.003 0.997 0.000
T38.1 Thyroid hormones and substitutes
0.000 0.997 0.002
T59.8 Other specified gases, fumes and vapours
0.000 0.997 0.003
W18.6 Industrial and construction area
0.002 0.997 0.000
O12.0 Gestational oedema
0.002 0.997 0.000
W18.9 Unspecified place
0.002 0.997 0.000
W18.8 Other specified place
0.002 0.997 0.000
W18.4 Street and highway
0.002 0.997 0.000
W18.2 School, other institution and public administrative area
0.002 0.997 0.000
W18.0 Home
0.002 0.997 0.000
W18.7 Farm
0.002 0.997 0.000
H18.7 Other corneal deformities
0.002 0.998 0.000
T42.4 Benzodiazepines
0.000 0.998 0.002
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.998 0.002
Z63.7 Other stressful life events affecting family and household
0.000 0.998 0.002
N02.9 Unspecified
0.000 0.998 0.002
F20.0 Paranoid schizophrenia
0.000 0.998 0.002
T50.8 Diagnostic agents
0.000 0.998 0.002
W18.1 Residential institution
0.002 0.998 0.000
Z63 Other problems related to primary support group, including family circumstances
0.000 0.998 0.002
H18.2 Other corneal oedema
0.002 0.998 0.000
O13 Gestational [pregnancy-induced] hypertension without significant proteinuria
0.002 0.998 0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.002 0.998 0.000
M82.10 Osteoporosis in endocrine disorders (Multiple sites)
0.002 0.998 0.000
G95.8 Other specified diseases of spinal cord
0.002 0.998 0.000
H18.1 Bullous keratopathy
0.002 0.998 0.000
N82.3 Fistula of vagina to large intestine
0.000 0.998 0.002
I98.8 Other specified disorders of circulatory system in diseases classified elsewhere
0.000 0.998 0.002
I98.1 Cardiovascular disorders in other infectious and parasitic diseases classified elsewhere
0.000 0.998 0.002
I98.0 Cardiovascular syphilis
0.000 0.998 0.002
M23.23 Derangement of meniscus due to old tear or injury (Medial collateral ligament or Other and unspecified medial meniscus)
0.000 0.998 0.002
D89.1 Cryoglobulinaemia
0.002 0.998 0.000
L90.8 Other atrophic disorders of skin
0.002 0.998 0.000
M82.1 Osteoporosis in endocrine disorders
0.002 0.998 0.000
L90.9 Atrophic disorder of skin, unspecified
0.002 0.998 0.000
D89 Other disorders involving the immune mechanism, not elsewhere classified
0.002 0.998 0.000
O14.0 Moderate preeclampsia
0.002 0.998 0.000
O73.0 Retained placenta, without haemorrhage
0.002 0.998 0.000
S91.3 Open wound of other parts of foot
0.002 0.998 0.000
O11 Pre-existing hypertensive disorder with superimposed proteinuria
0.002 0.998 0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified
0.002 0.998 0.000
O12 Gestational [pregnancy-induced] oedema and proteinuria without hypertension
0.002 0.998 0.000
D89.0 Polyclonal hypergammaglobulinaemia
0.002 0.998 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.998 0.002
O14.2 HELLP syndrome
0.002 0.998 0.000
O15 Eclampsia
0.002 0.998 0.000
L90.6 Striae atrophicae
0.002 0.998 0.000
L90.4 Acrodermatitis chronica atrophicans
0.002 0.998 0.000
L90.3 Atrophoderma of Pasini and Pierini
0.002 0.998 0.000
L90.2 Anetoderma of Jadassohn-Pellizzari
0.002 0.998 0.000
L90.1 Anetoderma of Schweninger-Buzzi
0.002 0.998 0.000
W18.09 Other fall on same level: Home: During unspecified activity
0.002 0.998 0.000
W18.04 Other fall on same level, Home , While resting, sleeping, eating or engaging in other vital activities
0.002 0.998 0.000
W18.22 Other fall on same level; School, other institution and public administrative area; While working for income
0.002 0.998 0.000
W18.49 Other fall on same level; Street and highway; During unspecified activity
0.002 0.998 0.000
W18.48 Other fall on same level; Street and highway; While engaged in other specified activities
0.002 0.998 0.000
W18.89 Other fall on same level; Other specified places; During unspecified activity
0.002 0.998 0.000
W18.99 Other fall on same level; Unspecified place; During unspecified activity
0.002 0.998 0.000
W18.93 Other fall on same level; Unspecified place; While engaged in other types of work
0.002 0.998 0.000
Z88.4 Personal history of allergy to anaesthetic agent
0.002 0.998 0.000
O10 Pre-existing hypertension complicating pregnancy, childbirth and the puerperium
0.002 0.998 0.000
T75.4 Effects of electric current
0.002 0.998 0.000
Y40.1 Cefalosporins and other -lactam antibiotics
0.000 0.998 0.002
G50 Disorders of trigeminal nerve
0.000 0.998 0.002
J93.8 Other pneumothorax
0.000 0.998 0.002
Z63.5 Disruption of family by separation and divorce
0.000 0.998 0.002
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified
0.002 0.998 0.000
Z63.9 Problem related to primary support group, unspecified
0.000 0.998 0.002
Z63.3 Absence of family member
0.000 0.998 0.002
Z63.2 Inadequate family support
0.000 0.998 0.002
Z63.1 Problems in relationship with parents and in-laws
0.000 0.998 0.002
S00.9 Superficial injury of head, part unspecified
0.000 0.998 0.002
T82.5 Mechanical complication of other cardiac and vascular devices and implants
0.002 0.998 0.000
Y45.4 Antirheumatics
0.002 0.998 0.000
Z63.6 Dependent relative needing care at home
0.000 0.998 0.002
Z63.8 Other specified problems related to primary support group
0.000 0.998 0.002
M82.19 Osteoporosis in endocrine disorders (Site unspecified)
0.002 0.998 0.000
M82.18 Osteoporosis in endocrine disorders (Other)
0.002 0.998 0.000
M82.17 Osteoporosis in endocrine disorders (Ankle and foot)
0.002 0.998 0.000
M82.16 Osteoporosis in endocrine disorders (Lower leg)
0.002 0.998 0.000
M82.15 Osteoporosis in endocrine disorders (Pelvic region and thigh)
0.002 0.998 0.000
M82.14 Osteoporosis in endocrine disorders (Hand)
0.002 0.998 0.000
M82.13 Osteoporosis in endocrine disorders (Forearm)
0.002 0.998 0.000
M82.12 Osteoporosis in endocrine disorders (Upper arm)
0.002 0.998 0.000
K86.9 Disease of pancreas, unspecified
0.000 0.998 0.002
D89.3 Immune reconstitution syndrome
0.002 0.998 0.000
H16.9 Keratitis, unspecified
0.002 0.998 0.000
O10.0 Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium
0.002 0.998 0.000
U51.1 Previously admitted to a psychiatric hospital of the provider
0.000 0.998 0.002
H90.7 Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
0.000 0.998 0.002
K86.8 Other specified diseases of pancreas
0.000 0.998 0.002
S91.0 Open wound of ankle
0.002 0.998 0.000
Y45.8 Other analgesics and antipyretics
0.002 0.998 0.000
Y40.0 Penicillins
0.000 0.998 0.002
G50.9 Disorder of trigeminal nerve, unspecified
0.000 0.998 0.002
O15.9 Eclampsia, unspecified as to time period
0.002 0.998 0.000
O15.2 Eclampsia in the puerperium
0.002 0.998 0.000
O15.1 Eclampsia in labour
0.002 0.998 0.000
O15.0 Eclampsia in pregnancy
0.002 0.998 0.000
T82.8 Other complications of cardiac and vascular prosthetic devices, implants and grafts
0.000 0.998 0.002
O10.4 Pre-existing secondary hypertension complicating pregnancy, childbirth and the puerperium
0.002 0.998 0.000
O10.3 Pre-existing hypertensive heart and renal disease complicating pregnancy, childbirth and the puerperium
0.002 0.998 0.000
O10.2 Pre-existing hypertensive renal disease complicating pregnancy, childbirth and the puerperium
0.002 0.998 0.000
O10.1 Pre-existing hypertensive heart disease complicating pregnancy, childbirth and the puerperium
0.002 0.998 0.000
Y45.5 4-Aminophenol derivatives
0.002 0.998 0.000
H04.9 Disorder of lachrymal system, unspecified
0.000 0.998 0.002
H60.9 Otitis externa, unspecified
0.002 0.998 0.000
Y45.1 Salicylates
0.002 0.998 0.000
J37 Chronic laryngitis and laryngotracheitis
0.002 0.998 0.000
J35.8 Other chronic diseases of tonsils and adenoids
0.000 0.998 0.002
K86.1 Other chronic pancreatitis
0.000 0.998 0.002
O73.1 Retained portions of placenta and membranes, without haemorrhage
0.002 0.998 0.000
Y40.8 Other systemic antibiotics
0.000 0.998 0.002
S91 Open wound of ankle and foot
0.002 0.998 0.000
Q27.3 Peripheral arteriovenous malformation
0.000 0.998 0.002
Y40.6 Rifamycins
0.000 0.998 0.002
H16.0 Corneal ulcer
0.002 0.998 0.000
H18.4 Corneal degeneration
0.002 0.998 0.000
L90.0 Lichen sclerosus et atrophicus
0.002 0.998 0.000
K86 Other diseases of pancreas
0.000 0.998 0.002
O10.9 Unspecified pre-existing hypertension complicating pregnancy, childbirth and the puerperium
0.001 0.998 0.000
C91.4 Hairy-cell leukaemia
0.002 0.998 0.000
N80.9 Endometriosis, unspecified
0.000 0.998 0.002
K86.2 Cyst of pancreas
0.000 0.998 0.002
N82.4 Other female intestinal-genital tract fistulae
0.000 0.998 0.002
O12.2 Gestational oedema with proteinuria
0.001 0.998 0.001
N82 Fistulae involving female genital tract
0.000 0.998 0.002
H61.1 Non-infective disorders of pinna
0.000 0.998 0.002
Y40 Systemic antibiotics
0.000 0.998 0.002
D89.9 Disorder involving the immune mechanism, unspecified
0.001 0.998 0.000
N82.9 Female genital tract fistula, unspecified
0.000 0.998 0.001
S91.1 Open wound of toe(s) without damage to nail
0.001 0.998 0.000
Z83.4 Family history of other endocrine, nutritional and metabolic diseases
0.000 0.998 0.002
H90.0 Conductive hearing loss, bilateral
0.000 0.998 0.001
Y40.4 Tetracyclines
0.000 0.998 0.001
G50.8 Other disorders of trigeminal nerve
0.001 0.998 0.001
J37.1 Chronic laryngotracheitis
0.001 0.998 0.000
N36.2 Urethral caruncle
0.001 0.998 0.000
O14.1 Severe preeclampsia
0.001 0.998 0.000
N82.8 Other female genital tract fistulae
0.000 0.999 0.001
G50.1 Atypical facial pain
0.000 0.999 0.001
R23.8 Other and unspecified skin changes
0.000 0.999 0.001
S91.7 Multiple open wounds of ankle and foot
0.001 0.999 0.000
S91.2 Open wound of toe(s) with damage to nail
0.001 0.999 0.000
N82.0 Vesicovaginal fistula
0.000 0.999 0.001
Z58.1 Exposure to air pollution
0.000 0.999 0.001
O73 Retained placenta and membranes, without haemorrhage
0.001 0.999 0.000
T59 Toxic effect of other gases, fumes and vapours
0.000 0.999 0.001
F40.0 Agoraphobia
0.000 0.999 0.001
H90.4 Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
0.000 0.999 0.001
K86.3 Pseudocyst of pancreas
0.000 0.999 0.001
T59.9 Gases, fumes and vapours, unspecified
0.000 0.999 0.001
F40.9 Phobic anxiety disorder, unspecified
0.000 0.999 0.001
H90.5 Sensorineural hearing loss, unspecified
0.000 0.999 0.001
N82.2 Fistula of vagina to small intestine
0.000 0.999 0.001
O12.1 Gestational proteinuria
0.001 0.999 0.000
Y40.2 Chloramphenicol group
0.000 0.999 0.001
S29.9 Unspecified injury of thorax
0.001 0.999 0.000
T14.9 Injury, unspecified
0.000 0.999 0.001
M79.54 Residual foreign body in soft tissue (Hand)
0.000 0.999 0.001
D37.4 Colon
0.000 0.999 0.001
N82.1 Other female urinary-genital tract fistulae
0.000 0.999 0.001
Q21.3 Tetralogy of Fallot
0.000 0.999 0.001
Q44.6 Cystic disease of liver
0.000 0.999 0.001
W64.9 Unspecified place
0.001 0.999 0.000
Y40.7 Antifungal antibiotics, systemically used
0.000 0.999 0.001
Y40.5 Aminoglycosides
0.000 0.999 0.001
H16 Keratitis
0.001 0.999 0.000
H90 Conductive and sensorineural hearing loss
0.000 0.999 0.001
H90.1 Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
0.000 0.999 0.001
J18.0 Bronchopneumonia, unspecified
0.001 0.999 0.000
F40.2 Specific (isolated) phobias
0.000 0.999 0.001
J93.1 Other spontaneous pneumothorax
0.000 0.999 0.001
N02.2 Diffuse membranous glomerulonephritis
0.000 0.999 0.001
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.999 0.001
T59.7 Carbon dioxide
0.000 0.999 0.001
T59.6 Hydrogen sulphide
0.000 0.999 0.001
T59.5 Fluorine gas and hydrogen fluoride
0.000 0.999 0.001
T59.4 Chlorine gas
0.000 0.999 0.001
T59.3 Lachrymogenic gas
0.000 0.999 0.001
T59.2 Formaldehyde
0.000 0.999 0.001
T59.1 Sulphur dioxide
0.000 0.999 0.001
T59.0 Nitrogen oxides
0.000 0.999 0.001
D39.1 Ovary
0.001 0.999 0.000
O00.9 Ectopic pregnancy, unspecified
0.001 0.999 0.000
Q65.8 Other congenital deformities of hip
0.001 0.999 0.000
S67.0 Crushing injury of thumb and other finger(s)
0.001 0.999 0.000
X59.2 School, other institution and public administrative area
0.000 0.999 0.001
Z37.2 Twins, both liveborn
0.000 0.999 0.001
B18.1 Chronic viral hepatitis B without delta-agent
0.000 0.999 0.001
F33.9 Recurrent depressive disorder, unspecified
0.000 0.999 0.001
M45.X9 Ankylosing spondylitis (Site unspecified)
0.000 0.999 0.001
N82.5 Female genital tract-skin fistulae
0.000 0.999 0.001
M86.67 Other chronic osteomyelitis (Ankle and foot)
0.000 0.999 0.001
L03.8 Cellulitis of other sites
0.000 0.999 0.001
Q21.1 Atrial septal defect
0.000 0.999 0.001
R01.0 Benign and innocent cardiac murmurs
0.001 0.999 0.000
T75.1 Drowning and nonfatal submersion
0.001 0.999 0.000
T75 Effects of other external causes
0.001 0.999 0.000
Z63.4 Disappearance and death of family member
0.000 0.999 0.001
H16.4 Corneal neovascularisation
0.001 0.999 0.000
I62.0 Subdural haemorrhage (acute) (nontraumatic)
0.001 0.999 0.000
O41.0 Oligohydramnios
0.000 0.999 0.001
Q65.0 Congenital dislocation of hip, unilateral
0.001 0.999 0.000
X59.3 Sports and athletics area
0.000 0.999 0.001
M43.62 Torticollis-Cervical
0.000 0.999 0.001
C83.3 Large cell (diffuse)
0.000 0.999 0.001
H21.5 Other adhesions and disruptions of iris and ciliary body
0.001 0.999 0.000
I23.8 Other current complications following acute myocardial infarction
0.000 0.999 0.001
K92.9 Disease of digestive system, unspecified
0.001 0.999 0.000
X44.2 School, other institution and public administrative area
0.000 0.999 0.001
N02 Recurrent and persistent haematuria
0.000 0.999 0.001
S62.30 Fracture of other metacarpal bone (closed)
0.001 0.999 0.000
N02.0 Minor glomerular abnormality
0.000 0.999 0.001
T17.9 Foreign body in respiratory tract, part unspecified
0.000 0.999 0.001
T75.8 Other specified effects of external causes
0.001 0.999 0.000
T75.3 Motion sickness
0.001 0.999 0.000
T75.2 Effects of vibration
0.001 0.999 0.000
T75.0 Effects of lightning
0.001 0.999 0.000
C15.5 Lower third of oesophagus
0.000 0.999 0.001
H90.2 Conductive hearing loss, unspecified
0.000 0.999 0.001
W29.9 Unspecified place
0.001 0.999 0.000
F40 Phobic anxiety disorders
0.000 0.999 0.001
H15.0 Scleritis
0.001 0.999 0.000
I08.2 Disorders of both aortic and tricuspid valves
0.001 0.999 0.000
L08.8 Other specified local infections of skin and subcutaneous tissue
0.001 0.999 0.000
X47.9 Unspecified place
0.000 0.999 0.001
X47.0 Home
0.000 0.999 0.001
Z54.0 Convalescence following surgery
0.000 0.999 0.001
E20.9 Hypoparathyroidism, unspecified
0.001 0.999 0.000
G70.9 Myoneural disorder, unspecified
0.001 0.999 0.000
H16.3 Interstitial and deep keratitis
0.001 0.999 0.000
H90.3 Sensorineural hearing loss, bilateral
0.000 0.999 0.001
N02.7 Diffuse crescentic glomerulonephritis
0.000 0.999 0.001
N02.6 Dense deposit disease
0.000 0.999 0.001
N02.5 Diffuse mesangiocapillary glomerulonephritis
0.000 0.999 0.001
N02.4 Diffuse endocapillary proliferative glomerulonephritis
0.000 0.999 0.001
N02.1 Focal and segmental glomerular lesions
0.000 0.999 0.001
X42.2 School, other institution and public administrative area
0.000 0.999 0.001
N02.3 Diffuse mesangial proliferative glomerulonephritis
0.000 0.999 0.001
N91.2 Amenorrhoea, unspecified
0.001 0.999 0.000
Q65.2 Congenital dislocation of hip, unspecified
0.001 0.999 0.000
Q87.4 Marfan's syndrome
0.001 0.999 0.000
W29.5 Trade and service area
0.001 0.999 0.000
S72.90 Fracture of femur, part unspecified (closed)
0.000 0.999 0.001
H15.9 Disorder of sclera, unspecified
0.001 0.999 0.000
H16.2 Keratoconjunctivitis
0.001 0.999 0.000
H19.1 Herpesviral keratitis and keratoconjunctivitis
0.000 0.999 0.001
Q65.9 Congenital deformity of hip, unspecified
0.001 0.999 0.000
R45.1 Restlessness and agitation
0.001 0.999 0.000
X43.0 Home
0.000 0.999 0.001
Y40.3 Macrolides
0.000 0.999 0.001
U51 Admission status on psychiatric patients
0.000 0.999 0.001
S12.00 Fracture of first cervical vertebra (closed)
0.000 0.999 0.001
D37.7 Other digestive organs
0.000 0.999 0.001
F40.8 Other phobic anxiety disorders
0.000 0.999 0.001
H15.8 Other disorders of sclera
0.001 0.999 0.000
H16.8 Other keratitis
0.001 0.999 0.000
H16.1 Other superficial keratitis without conjunctivitis
0.001 0.999 0.000
H60.4 Cholesteatoma of external ear
0.001 0.999 0.000
J86.9 Pyothorax without fistula
0.000 0.999 0.001
K86.0 Alcohol-induced chronic pancreatitis
0.000 0.999 0.001
W87.0 Home
0.001 0.999 0.000
H15 Disorders of sclera
0.001 0.999 0.000
M82 Osteoporosis in diseases classified elsewhere
0.001 0.999 0.000
X47 Accidental poisoning by and exposure to other gases and vapours
0.000 0.999 0.001
S52.00 Fracture of upper end of ulna (closed)
0.001 0.999 0.000
F40.1 Social phobias
0.000 0.999 0.001
H17.8 Other corneal scars and opacities
0.001 0.999 0.000
Q21.0 Ventricular septal defect
0.000 0.999 0.001
X49.6 Industrial and construction area
0.000 0.999 0.001
Z85.8 Personal history of malignant neoplasms of other organs and systems
0.001 0.999 0.000
X59 Exposure to unspecified factor
0.000 0.999 0.001
H15-H22 Disorders of sclera, cornea, iris and ciliary body
0.001 0.999 0.000
H19.2 Keratitis and keratoconjunctivitis in other infectious and parasitic diseases classified elsewhere
0.001 0.999 0.000
M82.8 Osteoporosis in other diseases classified elsewhere
0.001 0.999 0.000
M82.0 Osteoporosis in multiple myelomatosis
0.001 0.999 0.000
M82.3 Osteoporosis in diseases classified elsewhere, Forearm
0.001 0.999 0.000
Q65.1 Congenital dislocation of hip, bilateral
0.001 0.999 0.000
S46.2 Injury of muscle and tendon of other parts of biceps
0.001 0.999 0.000
S72.9 Fracture of femur, part unspecified
0.000 0.999 0.001
X47.8 Other specified place
0.000 0.999 0.001
X47.7 Farm
0.000 0.999 0.001
X47.5 Trade and service area
0.000 0.999 0.001
X47.4 Street and highway
0.000 0.999 0.001
X47.3 Sports and athletics area
0.000 0.999 0.001
X47.2 School, other institution and public administrative area
0.000 0.999 0.001
X47.1 Residential institution
0.000 0.999 0.001
J93 Pneumothorax
0.000 0.999 0.001
Q65 Congenital deformities of hip
0.001 0.999 0.000
X44 Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
0.000 0.999 0.001
C67.5 Bladder neck
0.000 0.999 0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.